Pyxis Oncology (NASDAQ:PYXS – Get Free Report) posted its quarterly earnings results on Friday. The company reported ($0.41) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.65) by $0.24, MarketWatch Earnings reports. Pyxis Oncology Stock Up 6.6 % PYXS stock opened at $2.58 on Monday. The business has a 50 day moving […]
Third dose cohort initiated in Phase 1 trial of PYX-201, Pyxis Oncology s first ADC product candidate Preliminary data from two Phase 1 trials on track for late 2023 to early 2024 Apexigen. -August 11, 2023 at 07:01 am- MarketScreener
Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate Update eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws.
NEW YORK, Aug. 11, 2023 /PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or.